Personalized Diagnostics in Melanoma

 

Related Videos (117)

Lynn Schuchter, MD, Chief, Division of Hematology/Oncology at Penn Medicine presents on the benefits of personalized diagnostics and genomic testing for patients with melanoma, with a focus on BRAF mutant melanoma and BRAF/MEK inhibitor therapy, and the ways oncologists are managing acquired resistance to therapy.

 

Penn PhysicianLink®

Penn PhysicianLink® is an exclusive program that helps all referring physicians connect with Penn Medicine. This comprehensive package of support services expedites and facilitates direct physician communication for patient consults, referrals and transfers.

Learn more about Penn PhysicianLink®